Trial Profile
A phase I trial of Doxil [doxorubicin liposomal] in children with solid tumors
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2005
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 07 Dec 2005 New trial record.